Treatment Options for Cough Variant Asthma
Qi Chang
Abstract
Qi Chang
Abstract
Objective:To choose a treatment for cough variant asthma with effective drugs,to compare ketotifen with montelukast joint MeipuQing,BDP spray.Method: The inclusion criteria found 120 cases of patients.They were randomly divided into two groups(60 cases each).Two groups were treated with meipuqing kechuanning ig,and Beclomethasone Dipropionanate Aerosol as basic treatment program.Control group was also given ketotifen(1 mg,2 times a day) orally.Observation group was also given montelukast(5 mg,qn) orally.Two groups were treated for 15 weeks as a course,then to evaluate the clinical efficacy.Result: The clinical control rate was 63.33%,95.00% total efficiency in observation group.Clinical control rate of the control group 46.67%,75.00% total efficiency in control group.The difference in two groups was significantly(P0.05).Daytime symptom scores,nighttime symptom score in the two groups were less than those before treatment 2(P0.05);but the observation group decreased more significant than the control group,group(P0.05).Forced expiratory volume in one second(FEV1) and FEV1% for 2 groups the difference before and after treatment were significant(P0.05).After treatment,2 groups showed significant difference(P0.05).The incidence of side effects in observation group was 3.33%;control group,10.00%.There was significant difference was P0.05.Conclusion: Montelukast and ketotifen are effective for cough variant asthma treatment,the therapeutic effect of montelukast is even better.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To choose a treatment for cough variant asthma with effective drugs,to compare ketotifen with montelukast joint MeipuQing,BDP spray.Method: The inclusion criteria found 120 cases of patients.They were randomly divided into two groups(60 cases each).Two groups were treated with meipuqing kechuanning ig,and Beclomethasone Dipropionanate Aerosol as basic treatment program.Control group was also given ketotifen(1 mg,2 times a day) orally.Observation group was also given montelukast(5 mg,qn) orally.Two groups were treated for 15 weeks as a course,then to evaluate the clinical efficacy.Result: The clinical control rate was 63.33%,95.00% total efficiency in observation group.Clinical control rate of the control group 46.67%,75.00% total efficiency in control group.The difference in two groups was significantly(P0.05).Daytime symptom scores,nighttime symptom score in the two groups were less than those before treatment 2(P0.05);but the observation group decreased more significant than the control group,group(P0.05).Forced expiratory volume in one second(FEV1) and FEV1% for 2 groups the difference before and after treatment were significant(P0.05).After treatment,2 groups showed significant difference(P0.05).The incidence of side effects in observation group was 3.33%;control group,10.00%.There was significant difference was P0.05.Conclusion: Montelukast and ketotifen are effective for cough variant asthma treatment,the therapeutic effect of montelukast is even better.
Key concepts: Ketotifen, Montelukast, Medicine, Anesthesia, Significant difference, Asthma, Incidence (geometry), Treatment and control groups